Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice

Experimental Cell Research

Volumn 279, Issue 2, 2002, Pages 299-309

  Shim, Winston S N ^a   Teh, Ming ^a   Bapna, Akanksha ^a   Kim, Injune ^c   Koh, Gou Young ^c   Mack, Peter O P ^b   Ge, Ruowen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Angiopoietin 1; Tumor angiogenesis; Vessel plasticity

Indexed keywords

ANGIOPOIETIN 1; RECOMBINANT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD VESSEL; CANCER GROWTH; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; GENE TRANSFER; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT GENE; TUMOR; TUMOR CELL; TUMOR GROWTH; UTERINE CERVIX CANCER;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 0036405427     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5597     Document Type: Article

References (53)

1. Folkman, J. (1972). Anti-angiogenesis: New concept for therapy of solid tumors. Ann. Surg. 175, 409-416.
2. Bicknell, R. (1994). Vascular targeting and the inhibition of angiogenesis. Ann. Oncol. 5, S45-S50.
3. Kondos, S., Asano, M., and Suzuki, H. (1993). Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem. Biophys. Res. Commun. 194, 1234-1241.
4. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. (1994). Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-579.
5. Prewett, M., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K., Overholser, J., Hooper, A., Pytowski, B., Witte, L., Bohlen, P., and Hicklin, D. J. (1999). Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 59, 5209-5218.
6. Strawn, L. M., McMahon, G., App, H., Schreck, R., Kuchler, W. R., Longhi, M. P., Hui, T. H., Tang, C., Levitzki, A., Gazit, A., Chen, I., Keri, G., Orfi, L., Risau, W., Flamme, I., Ullrich, A., Hirth, K. P., and Shawver, L. K. (1996). Flk-1 as a target for tumor growth inhibition. Cancer Res. 56, 3540-3545.
7. Koblizek, T. I., Weiss, C., Yancopoulos, G. D., Deutsch, U., and Risau, W. (1998). Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8, 529-532.
8. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McCain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. M. J., Davis, S., Sato, T. N., and Yancopoulos, G. D. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60.
9. Papapetropoulos, A., Fulton, D., Mahboubi, K., Kalb, R. G., O'Connor, D. S., Li, F., Altieri, D. C., and Sessa, W. C. (2000). Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem. 275, 9102-9105.
10. Wong, A. L., Haroon, Z. A., Werner, S., Dewhirst, M. W., Greenberg, C. S., and Peters, K. G. (1997). Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ. Res. 81, 567-574.
11. Beck, L., and D'Amore, P. A. (1997). Vascular development: Cellular and molecular regulation. FASEB J. 11, 365-373.
12. Folkman, J., and D'Amore, P. A. (1996). Blood vessel formation: What is its molecular basis. Cell 87, 1153-1155.
13. Ding, H., Roncari, L., Wu, X., Lau, N., Shannon, P., Nagy, A., and Guha, A. (2001). Expression and hypoxic regulation of angiopoietins in human astrocytomas. Neuro-Oncology 3, 1-10.
14. Eggert, A., Ikegaki, N., Kwiatkowski, J., Zhao, H., Brodeur, G. M., and Himelstein, B. P. (2000). High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin. Cancer Res. 6, 1900-1908.
15. Goede, V., Schmidt, T., Kimina, S., Kozian, D., and Augustin, H. G. (1998). Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 78, 1385-1394.
16. Hazzard, T. M., Christenson, L. K., and Stouffer, R. L. (2000). Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle. Mol. Hum. Reprod. 6, 993-998.
17. Stratmann, A., Risau, W., and Plate, K. H. (1998). Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153, 1459-1466.
18. Bunone, G., Vigneri, P., Mariani, L., Buto, S., Collini, P., Pilotti, S., Pierotti, M. A., and Bongarzone, I. (1999). Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am. J. Pathol. 155, 1967-1976.
19. Cohen, B., Barkan, D., Levy, Y., Goldberg, I., Fridman, E., Kopolovic, J., and Rubinstein, M. (2001). Leptin induces angiopoietin-2 expression in adipose tissues. J. Biol. Chem. 276, 7697-7700.
20. Yu, Q., and Stamenkovic, I. (2001). Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am. J. Pathol. 158, 563-570.
21. Shim, W. S. N., Teh, M., Mack, P. O., and Ge, R. (2001). Inhibition of angiopoietin-1 expression in tumor cells by an antisense RNA approach inhibited xenograft tumor growth in immunodeficient mice. Int. J. Cancer 94, 6-15.
22. Kim, I., Kim, H. G., Kim, H., Kim, H. H., Park, S. K., Uhm, C. S., Lee, Z. H., and Koh, G. Y. (2000). Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 346, 603-610.
23. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. (1991). Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-8.
24. Huovinen, R., Warri, A., and Collan, Y. (1993). Mitotic activity, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with anti-estrogen toremifene. Int. J. Cancer 55, 685-691.
25. Lipponen, P., and Aaltomaa, S. (1994). Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J. Pathol. 173, 333-339.
26. Chiarotto, J. A., and Hill, R. P. (1999). A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines. Br. J. Cancer 80, 15-18.
27. Benjamin, L. E., Hemo, I., and Keshet, E. (1998). A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591-1598.
28. Martoglio, A. M., Tom, B. D. M., Starkey, M., Corps, A. N., Charnock-Jones, D. S., and Smith, S. K. (2000). Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA array. Mol. Med. 6, 750-765.
29. Shirakawa, K., Tsuda, H., Heike, Y., Kato, K., Asada, R., Inomata, M., Sasaki, H., Kasumi, F., Yoshimoto, M., Iwanaga, T., Konishi, F., Terada, M., and Wakasugi, H. (2001). Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res. 61, 445-451.
30. Takahama, M., Tsutsumi, M., Tsujiuchi, T., Nezu, K., Kushibe, K., Taniguchi, K., Kotake, Y., and Konishi, Y. (1999). Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas. Clin. Cancer Res. 5, 2506-2510.
31. NicAmhlaoibh, R., and Shtivelman, E. (2001). Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro. Oncogene 20, 270-275.
32. Ahmad, S. A., Liu, W., Jung, Y. D., Fan, F., Wilson, M., Reinmuth, N., Shaheen, R. M., Bucana, C., and Ellis, L. M (2001). The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res. 61, 1255-1259.
33. Hayes, A. J., Huang, W. Q., Yu, J., Maisonpierre, P. C., Liu, A., Kern, F. G., Lippman, M. E., McLeskey, S. W., and Li, L. Y. (2000). Expression and function of angiopoietin-1 in breast cancer. Br. J. Cancer 83, 1154-1160.
34. Tian, S., Hayes, A. J., Metheny-Barlow, L. J., and Li, L.-Y. (2002) Stabilization of breast cancer xenograft tumor neovascularization by angiopoietin-1. Br. J. Cancer 86, 645-651.
35. Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., and Wiegand, S. J. (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoietins and vegf. Science 284, 1994-1998.
36. Pezzella, F., Pastorino, U., Tagliabue, E., Andreola, S., Sozzi, G., Gasparini, G., Menard, S., Gatter, K. C., Harris, A. L., Fox, S., Buyse, M., Pilotti, S., Pierotti, M., and Rilke, F. (1997). Non-small-cell lung carcinoma tumor growth without morphological evidence of neoangiogenesis. Am. J. Pathol. 151, 1417-1423.
37. Korff, T., Kimmina, S., Martiny-Baron, G., and Augustin, H. G. (2001). Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 15, 447-457.
38. Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159-165.
39. Lindahl, P., Hellstrom, M., Kalen, M., and Betsholtz, C. (1998). Endothelial-perivascular cell signaling in vascular development: Lessons from knockout mice. Curr. Opin. Lipidol. 9, 407-411.
40. Jones, N., Iljin, K., Dumont, D. J., and Alitalo, K. (2001). Tie receptors: New modulators of angiogenic and lymphangiogenic responses. Nat. Rev. 2, 257-267.
41. Jones, N., Voskas, D., Master, Z., Sarao, R., Jones, J., and Dumont, D. J. (2001). Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep. 21, 438-445.
42. Puri, M. C., Partanen, J., Rossant, J., and Bernstein, A. (1999). Interaction of the Tek and Tie receptor tyrosine kinases during cardiovascular development. Development 126, 4569-4580.
43. Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., and Yancopoulos, G. D. (1998). Increased vascularization in mice overexpressing angiopoietins-1. Science 282, 469-471.
44. Pola, R., Ling, L. E., Silver, M., Corbley, M. J., Kearney, M., Pepinsky, R. B., Shapiro, R., Taylor, F. R., Baker, D. P., Asahara, T., and Isner, J. M. (2001). The morphogen sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat. Med. 7, 706-711.
45. Gale, N. W., Baluk, P., Pan, L., Kwan, M., Holash, J., DeChiara, T. M., McDonald, D. M., and Yancopoulos, G. D. (2001). Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev. Biol. 230, 151-160.
46. Wang, H. U., Chen, Z. F., and Anderson, D. J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753.
47. Shin, D., Garcia-Cardena, G., Hayashi, S. I., Gerety, S., Asahara, T., Stavrakis, G., Isner, J., Folkman, J., Gimbrone, M. A., and Anderson, D. J. (2001). Expression of ephrin-B2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev. Biol. 230, 139-150.
48. Audero, E., Cascone, I., Zanon, I., Previtali, S. C., Piva, R., Schiffer, D., and Bussolino, F. (2001). Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: In vivo and in vitro studies. Arterioscler. Thromb. Vasc. Biol. 21, 536-541.
49. Shepro, D., and Morel, N. M. L. (1993). Pericyte physiology. FASEB J. 7, 1031-1038.
50. Charnock-Jones, D. S., and Burton, G. J. (2000). Placenta vascular morphogenesis. Bailliere's Clin. Obstet. Gynecol. 14, 953-968.
51. Currie, M. J., Gunningham, S. P., Han, C., Scott, P. A. E., Robinson, B. A., Harris, A. L., and Fox, S. B. (2001). Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling. Clin. Cancer Res. 7, 918-927.
52. Huang, Y. Q., Li, J. J., and Karpatkin, S. (2000). Identification of a family of alternatively spliced mRNA species of angiopoietin-1. Blood 95, 1993-1999.
53. Marron, M. B., Hughes, D. P., Edge, M. D., Forder, C. L., and Brindle, N. P. J. (2000). Evidence of heterotypic interaction between the receptor tyrosine kinases Tie-1 and Tie-2. J. Biol. Chem. 275, 39741-39746.